Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Real estate agent Kirsten Jordan breaks down the latest trends in the housing market, near-record home sale cancellations in April and her outlook on mortgage rates. Myasthenia gravis is a rare, ...

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) ...

Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization in the United States ...

The Phase 3 AURORA trial tests Descartes-08 against a placebo in patients with acetylcholine receptor autoantibody positive myasthenia gravis. How many participants are enrolled in the AURORA trial?

Neurology of Central Florida Dr. Alicia Cabrera is an adult neurologist with over 25 years of experience in the field. She’s ...

RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of ...

today announced that the first participant has been enrolled in its Phase 3 AURORA trial of Descartes-08 in patients with myasthenia gravis (MG). Descartes-08, Cartesian’s lead cell therapy ...

The American Oncology Institute (AOI) in Guntur has successfully treated a rare and complex case of Myasthenia Gravis ...

Rare disease community members take action in June to spread awareness and advocate for better treatments and a cure for myasthenia gravis Global MG Community turns Awareness into Action to ...